Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lecce
Clinical trial register · Italy

Clinical Trials in Lecce, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 Medtronic4 Janssen Research & Development, LLC3 Bayer2 Università Vita-Salute San Raffaele2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Lecce

70 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
AI-Based Video Assessment of Anterior Knee Laxity
NCT07833605ACL - Anterior Cruciate Ligament Deficiency
ASL Lecce
Observational
70
Lecce
2026-09-15
Recruiting
Bayer
Phase 4
50
Bergamo, Bologna, Florence, Lecce, Milan, Naples, Padova, Pavia
2026-02-13
Recruiting
Meyer Children's Hospital IRCCS
Observational
500
Florence, Bergamo, Brescia, Catania, Lecce, Modena, Novara, Padova
2026-02-05
Not yet open
Warfarin Effects on Male Fertility After Cardiac Surgery
NCT07330869Male Infertility, Heart Valve Disease
Città di Lecce Hospital, GVM Care & Research
Observational
90
Lecce
2026-02
Recruiting
Novartis Pharmaceuticals
Observational
250
Ancona, Bari, Brescia, Cona, Florence, Genova, Lecce, Messina
2025-12-17
Recruiting
Eli Lilly and Company
Phase 3
1,630
Bologna, Catania, Lecce, Lucca, Milan, Modena, Naples, Prato
2025-10-22
Recruiting
Laboratoires Thea
Observational
200
Bologna, Catania, Corigliano, Genova, Lecce, Lucca, Modena, Morrovalle
2025-09-19
Recruiting
A New Portable Device for Non-invasive Ventilatory Support
NCT06716502Healthy, Respiratory Disease
Università Vita-Salute San Raffaele
Not applicable
50
Lecce, Milan, Verona
2025-09-17
Recruiting
Hoffmann-La Roche
Observational
700
Lecce, Naples, Modena, Ravenna, Rome, Genoa, Bergamo, Milan
2025-07-15
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Ancona, Bologna, Brescia, Florence, Forlì, Lecce, Milan, Naples
2025-07-02
Active, closed
Sanofi
Phase 3
1,092
Rome, Bari, Foggia, Lecce, Milan, Parma
2025-05-22
Active, closed
Racial Disparities in Acute Stroke
NCT06955442Ischemic Stroke
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
4,500
Bologna, Crema, Frosinone, Genova, Lecce, Naples, Pavia, Pozzilli
2025-04-03
Recruiting
BeOne Medicines
Phase 3
300
Bologna, Lecce, Meldola, Trieste, Verona
2025-03-05
Recruiting
ASL Lecce
Observational
80
Lecce
2025-02-01
Active, closed
mAbxience Research S.L.
Phase 3
726
Brescia, Cremona, Genova, Lecce, Meldola, Pavia, Roma, Siena
2024-12-30
Recruiting
OSE Immunotherapeutics
Phase 3
363
Meldola, San Filippo, Rozzano, Naples, Orbassano, Legnago, Genova, Lecce
2024-12-03
Recruiting
Sustained Endogenous Attention Deficits in Attention Deficit Hyperactivity Disorder
NCT06900400ADHD - Attention Deficit Disorder With Hyperactivity
IRCCS Eugenio Medea
Not applicable
50
Brindisi, Lecce
2024-11-11
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
31
Florence, Lecce, Roma
2024-10-17
Recruiting
Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis
NCT06664112Delivery Complication, Delivery Problem, Delivery; Injury, Delivery; Injury, Maternal
Centro di Ricerca Clinica Salentino
Observational
1,000
Scorrano, Lecce
2024-09-30
Recruiting
Valerio Nardone
Observational
1,000
Barletta, Campobasso, Lecce, Naples, Potenza, Roma
2024-09-06
Recruiting
Bayer
Phase 3
555
Avellino, Aviano, Bologna, Florence, Lecce, Meldola, Milan, Orbassano
2024-08-28
Not yet open
Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)
NCT06060847Carcinoma, Hepatocellular, Metabolic Syndrome
Ospedale V. Fazzi
Not applicable
50
Lecce
2024-03-06
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bologna, Candiolo, Catania, Lecce, Meldola, Messina, Milan, Naples
2024-02-05
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Meldola, Ancona, Bologna, Brescia, Lecce, Ravenna, Roma, Rozzano
2024-01-05
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Aviano, Brescia, Cona, Genova, Lecce, Meldola, Milan, Padova
2023-12-20
Recruiting
Janssen-Cilag Ltd.
Observational
900
Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo
2023-12-18
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Alessandria, Chieti, Città di Castello, Empoli, Lecce, Lecco, Legnago, Legnano
2023-10-24
Recruiting
Rescue Stenting and Intravenous Thrombolysis In Patients With Large Vessel Ischemic Stroke
NCT06727006Large Vessel Occlusion, Stroke Acute, Thrombolysis, Rescue Stenting
ASST Santi Paolo e Carlo
Observational
400
Bergamo, Cesena, Lecce, Milan, Monza, Pietra Ligure
2023-10-21
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Bologna, Castelfranco Veneto, Cuneo, Latina, Lecce, Milan, Modena, Pavia
2023-09-05
Recruiting
AstraZeneca
Observational
52,121
Lecce, Messina, Milan
2023-08-21
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Active, closed
Bristol-Myers Squibb
Phase 3
606
Meldola, Milan, Rozzano, Bologna, Catanzaro, Lecce, Pisa, Udine
2023-01-10
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Bergamo, Bologna, Castelfranco Veneto, Florence, Lecce, Milan, Naples, Roma
2022-12-29
Active, closed
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
NCT05306301Chemotherapy, Leukemia, Acute Lymphoblastic
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
32
Avellino, Pagani, Bergamo, Bologna, Brescia, Catania, Florence, Lecce
2022-10-05
Active, closed
Redx Pharma Ltd
Phase 2
48
Ancona, Catania, Foggia, Lecce, Milan, Modena, Roma, Verona
2022-09-08
Recruiting
AIOCC Italian Registry on Head and Neck Carcinomas
NCT06248944Head and Neck Carcinoma
Italian Head&Neck Society
Observational
7,000
Candiolo, Florence, Lecce, Milan, Pavia, Roma, Verona
2022-07-06
Recruiting
Priothera SAS
Phase 3
366
Brindisi, Reggio Calabria, San Giovanni Rotondo, Lecce, Roma, Alessandria, Ascoli Piceno, Florence
2022-06-16
Recruiting
Meyer Children's Hospital IRCCS
Observational
290
Florence, Bari, Brescia, Catanzaro, Lecce, Milan, Padova, Pavia
2022-02-10
Recruiting
Janssen Pharmaceutica N.V., Belgium
Observational
300
Bari, Bologna, Catania, Civitanova Marche, Genova, Lecce, Meldola, Padova
2021-11-18
Active, closed
Amgen
Phase 3
303
Bari, Bergamo, Bologna, Genova, Lecce, Mestre (VE), Milan, Naples
2021-11-02
Recruiting
Corcym S.r.l
Observational
2,150
Ancona, Bologna, Brescia, Lecce, Massa, Milan, Naples, Palermo
2021-06-29
Recruiting
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
IRCCS San Raffaele
Observational
800
Bergamo, Bologna, Brescia, Lecce, Milan, Novara, Parma, Roma
2021-05-25
Active, closed
Incyte Corporation
Phase 3
899
Bergamo, Brescia, Candiolo, Catania, Forlì, Genoa, Lecce, Milan
2021-05-11
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Arezzo, Candiolo, Cremona, Lecce, Meldola, Milan, Naples, Orbassano
2020-09-23
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
Medtronic
Observational
2,200
Bologna, Cosenza, Lecce, Milan, Taranto, Udine
2020-08-01
Active, closed
Medtronic
Observational
2,200
Bologna, Castrovillari, Lecce, Milan, Taranto, Udine
2020-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Torrette, Rome, Rozzano, Florence, Lecce, Milan, Modena, Udine
2020-07-06
Active, closed
Epizyme, Inc.
Phase 3
599
Naples, Meldola, Brescia, Catania, Florence, Lecce, Milan, Monza
2020-06-11
Recruiting
Federico II University
Observational
5,000
Arzignano, Bari, Caserta, Catanzaro, Eboli, Foggia, Genova, Lecce
2020-03-07
Recruiting
Comprehensive Aneurysm Management Trial
NCT04155606Saccular Aneurysm, Intracranial Aneurysm, Unruptured Cerebral Aneurysm
Centre hospitalier de l'Université de Montréal (CHUM)
Not applicable
2,000
Bergamo, Lecce, Milan
2020-01-15
Recruiting
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement
DrugWarfarin
Population Health Research Institute
Phase 3
2,625
Lecce, Alessandria, Ancona, Foggia
2019-09-05
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Active, closed
Tesaro, Inc.
Phase 3
785
Candiolo, Carpi MO, Lecce, Milan, Naples, Ponderano BI, Rome, Sassuolo
2019-07-18
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
Università Vita-Salute San Raffaele
Not applicable
2,000
Cotignola, Catania, Lecce, Milan, Padua, Pisa, Potenza, Rome
2019-04-15
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Florence, Lecce, Milan, Naples, Province of Macerata
2018-03-02
Active, closed
Medtronic
Observational
1,092
Bologna, Castrovillari, Lecce, Milan, Taranto, Udine
2017-08-21
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Active, closed
Eisai Inc.
Phase 3
1,069
Faenza, Arezzo, Bologna, Genova, Lecce, Meldola, Milan, Modena
2016-10-13
Active, closed
Tesaro, Inc.
Phase 3
733
Lecce, Milan, Modena, Naples
2016-07-11
Active, closed
AstraZeneca
Phase 3
1,837
Bergamo, Bologna, Bolzano, Castellanza Varese, Lecce, Legnago, Milan, Modena
2014-04-22
Recruiting
PREgnancy and FERtility Registry
NCT02895165Breast Neoplasms, Pregnancy, Fertility Preservation
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Observational
1,000
Asti, Brindisi, Monserrato, Cuneo, Cona, Genoa, Lecce, Lido di Camaiore
2012-11
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan
1983-01
Rows per page Showing 1–70 of 70
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-italy/city/lecce

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 70 of those studies with a site in Lecce.

How many clinical trials are recruiting in Lecce?

35 of the 70 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 32 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lecce), 70 studies
PhaseStudiesRecruitingShare
Phase 3301142.9%
Observational261937.1%
Phase 27110%
Not applicable537.1%
Phase 1/2101.4%
Phase 4111.4%

Most active sponsors

Lead sponsors with the most studies (Lecce)
Lead sponsorStudiesRecruiting
AstraZeneca51
Medtronic41
Janssen Research & Development, LLC30
Ascentage Pharma Group Inc.22
ASL Lecce21
Bayer22
Bristol-Myers Squibb20
Gruppo Italiano Malattie EMatologiche dell'Adulto20
Incyte Corporation20
Meyer Children's Hospital IRCCS22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.